COLLPLANT BIOTECHNOLOGIES LT shareholders Q3 2023

COLLPLANT BIOTECHNOLOGIES LT's ticker is CLGN and the CUSIP is M2R51X116. A total of 18 filers reported holding COLLPLANT BIOTECHNOLOGIES LT in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

COLLPLANT BIOTECHNOLOGIES LT shareholders Q3 2023
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 577,909$3,253,6286.54%
VILLERE ST DENIS J & CO LLC 300,173$1,671,9630.14%
PINNACLE ASSOCIATES LTD 478,309$2,664,1810.05%
BENJAMIN F. EDWARDS & COMPANY, INC. 45,050$2540.01%
FNY Investment Advisers, LLC 1,539$80.01%
Zurcher Kantonalbank (Zurich Cantonalbank) 23,140$130,2780.00%
BROWN ADVISORY INC 74,836$416,8370.00%
Geneos Wealth Management Inc. 750$4,2230.00%
Focused Wealth Management, Inc 242$1,3480.00%
UBS Group AG 5,690$31,6930.00%
NewEdge Advisors, LLC 500$2,7850.00%
BANK OF AMERICA CORP /DE/ 7,300$40,6610.00%
PNC FINANCIAL SERVICES GROUP, INC. 3,600$20,0520.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 121$6740.00%
NATIONAL BANK OF CANADA /FI/ 250$1,4160.00%
SIMPLEX TRADING, LLC 100$00.00%
Qube Research & Technologies Ltd 6$340.00%
External links

This page lists COLLPLANT BIOTECHNOLOGIES LT's shareholders in Q3 2023. To view COLLPLANT BIOTECHNOLOGIES LT's shareholder history, click here.